Nymox Pharmaceutical • NYMX
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Paul Averback,M.D.,D.A.B.P.1995
(há 29 anos)
1997
(27 years ago)
NASDAQ
Listagem
Nassau
3
N° de Empregados • 2021Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NYMXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.